A carregar...
In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates
Objective: Ciprofloxacin resistance (CIP(R)) for Shigella isolates is becoming more prevalent. This study systematically investigated the antibacterial activity of ciprofloxacin (CIP)/fosfomycin (FOS) combination in vitro and in vivo against CIP(R) S. flexneri isolates. Method: Eighty CIP(R) S. flex...
Na minha lista:
| Publicado no: | Infect Drug Resist |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6580129/ https://ncbi.nlm.nih.gov/pubmed/31354311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S208071 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|